PHIBRO ANIMAL HEALTH CORP

Phibro Animal Health Corporation develops, manufactures, and sells animal health and mineral nutrition products, alongside specialty industrial chemicals. The business operates across three segments: Animal Health, Mineral Nutrition, and Performance Products. Offerings include antibacterials, anticoccidials, nutritional specialty products, vaccines, vaccine adjuvants, ethanol fermentation aids, fortifying mineral diets, and chemical catalyst ingredients. The company serves livestock producers, animal feed manufacturers, wholesalers, distributors, veterinarians, and industrial clients, targeting food animals such as poultry, cattle, and swine, as well as companion animals.

The company markets approximately 790 product lines to around 4,800 customers in about 90 countries. Its operations extend across North America, Latin America, Asia Pacific, Europe, Africa, and the Middle East, with manufacturing facilities in the United States, Italy, and China. Phibro is incorporated in Delaware, though the provided text does not state a headquarters location.

Summary of the business section of Phibro Animal Health's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

“As of June 30, 2026, we had approximately 2,605 employees in 75 locations spanning 37 countries.”